Research / Literature

Research Literature

Here you can search a selected list of NGAL literature relevant for research purposes.

Use the filters to the left to choose from a number of relevant areas or product relation.


Segev G (2013) J Vet Intern Med Sep 10

Acute kidney injury (AKI) is a common and often fatal disorder in dogs. Urine neutrophil gelatinase-associated lipocalin (NGAL)/creatinine ratio is a sensitive and specific biomarker of AKI in ninety-four dogs.

Read more
Source
http://www.ncbi.nlm.nih.gov/pubmed/24020513
Date

Huber W (2012) J CLI 36:10-12

Sepsis frequently results in acute kidney injury (AKI). Although AKI markedly contributes to mortality in sepsis, its diagnosis is frequently delayed due to limitations of current biomarkers of renal impairment. Neutrophil-gelatinase-associated lipocalin (NGAL) has been demonstrated to be a biomarker of early AKI.

To download as pdf please click here 

Read more
Source
http://www.cli-online.com/featured-articles/early-detection-of-acute-kidney-injury-in-sepsis-how-about-ngal/index.html
Date

Jeong TD (2012) Clin Transplant

An evaluation of the utility of urine and plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations as biomarkers of AKI during and after liver transplantation.

Read more
Source
http://www.ncbi.nlm.nih.gov/pubmed/22404749
Date

Hosgood SA (2012) J Surg Res 15;174(2):e85-90

Early urinary biomarkers are a useful means to determine graft injury. ET-1 and NGAL are more accurate in predicting the severity of ischemic injury compared with inflammatory markers

Read more
Source
http://www.ncbi.nlm.nih.gov/pubmed/22221604
Date

Jochmans I (2011) Ann Surg 254:784–792

The objective is to investigate circulating biomarkers of initial graft injury in a porcine kidney autotransplant model.

Read more
Source
http://www.ncbi.nlm.nih.gov/pubmed/21997818
Date

Ostermann M (2011) J CLI 35:10-12

Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a promising biomarker for acute kidney injury (AKI). The ultimate goal is for NGAL to enable clinicians to intervene as early as possible and to change the prognosis of AKI.

To download as pdf please click here

Read more
Source
http://www.cli-online.com/index.php?id=3198
Date

Ricci Z (2011) Crit Care 29;15:R160

A study of Fenoldopam efficacy as a pretreatment to avoid AKI on cardiopulmonary bypass pediatric patients using NGAL for definition of AKI...

Read more
Source
http://www.ncbi.nlm.nih.gov/pubmed/21714857
Date